The Clinical Value of Measuring the (1-3)-β-D-Glucan and Galactomannan for Diagnosis of Invasive Fungal Disease

Yi-ling ZHU,Juan-juan CUI,Jian-he GAN

DOI: https://doi.org/10.3969/j.issn.1009-881X.2014.01.044

2014-01-01

Abstract:Objective To evaluate the (1-3)-β-D Glucan and Galactomannan for diagnosis of invasive fungal disease (IFD). Methods A retrospective study was performed on 231 cases of hospitalized patients of the First Affiliated Hospital of Soochow University who were at risk of IFD. The diagnosis of IFD was according to revised definitions. Galactomannan enzyme immunoassay (GM test) and (1-3)-β-D glucan assay (G test) were analyzed of sensitivity, specificity, and concordance rate, respectively. Two tests were combined to evaluate the changes of sensitivity, specificity, and concordance rate. Results The sensitivity and specificity were 50.0%, 91.5%in G test;70.2%, 83.7%in GM test;and 92.7%, 78.9%in combined utility of two tests. Conclusion The G test and GM test were both useful in diagnosis of IFD. The better sensitivity and concordance rate might be acquired by combining these two tests.